Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Subst Abuse Treat. 2019 Oct 24;108:115–122. doi: 10.1016/j.jsat.2019.08.006

Table 2.

Depression severity, treatment needs, and overdose history of total pilot sample and subsamples.

Total (N=36)
N (%) or M ± SD
Subsample (n=19)
N (%) or M ± SD
Excluded (n=17)
N (%) or M ± SD
Patient Health Questionnaire (PHQ)
 Minimal depression 6 (16.7%) 4 (21.1%) 2 (11.8%)
 Mild depression 10 (27.8%) 6 (31.6%) 4 (23.5%)
 Moderate depression 11 (30.6%) 5 (26.3%) 6 (35.3%)
 Moderately severe depression 6 (16.7%) 2 (10.5%) 4 (23.5%)
 Severe depression 3 (8.3%) 2 (10.5%) 1 (5.9%)
 Mean score 10.8 ±6.2 10.4 ±6.8 11.2 ±5.6
Treatment Needs
Questionnaire (TNQ)
 Excellent candidate for office based treatment 2 (5.6%) 1 (5.3%) 1 (5.9%)
 Good candidate for office based treatment with onsite counseling 6 (16.7%) 4 (21.1%) 2 (11.8%)
 Candidate for office based treatment in as tightly structured program 20 (55.6%) 11 (57.9%) 9 (52.9%)
 Opioid treatment program only 8 (22.2%) 3 (15.8%) 5 (29.4%)
 Mean Score 12.313.8 11.6 ±3.2 13.1 ±4.4
Overdose History
 Had overdosed on opioids 18 (50.0%) 11 (57.9%) 7 (41.2%)
 Times overdosed on opioids 1.7 ±2.2 2.0 ±2.4 1.4 ±2.0

Subsample = Participants with an OUD diagnosis of OUD in EHR over 3 months.

Excluded= Participants without an OUD diagnosis of OUD in EHR over 3 months.